Tumor Microenvironment Remodeling Mediates Resistance to 177Lu-DOTATATE in Metastatic Well-Differentiated Neuroendocrine Tumors (NANETS 2026) - Oct 7, 2026 - Pres time: Nov 6, 2026; 03:35 PM - 04:50 PM; No abstract available
Biomarker • Metastases • Tumor microenvironment • Neuroendocrine Tumor • Oncology • Solid Tumor
|